Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81M Buy
6,991,763
+3,811,622
+120% +$21.5M 0.02% 701
2026
Q1
$9.54M Sell
3,180,141
-16,436
-0.5% -$47.6K ﹤0.01% 1963
2025
Q4
$11.2M Buy
3,196,577
+5,566
+0.2% +$20.3K ﹤0.01% 1823
2025
Q3
$9.7M Buy
3,191,011
+625,451
+24% +$1.73M ﹤0.01% 1932
2025
Q2
$6.59M Sell
2,565,560
-22,672
-0.9% -$63.8K ﹤0.01% 2141
2025
Q1
$6.5M Sell
2,588,232
-7,922
-0.3% -$29.1K ﹤0.01% 2110
2024
Q4
$6.8M Sell
2,596,154
-23,668
-0.9% -$83.3K ﹤0.01% 2120
2024
Q3
$10M Buy
2,619,822
+2,490,082
+1,919% +$9.9M ﹤0.01% 1803
2024
Q2
$400K Buy
129,740
+6,240
+5% +$28.9K ﹤0.01% 3493
2024
Q1
$701K Sell
123,500
-4,000
-3% -$18K ﹤0.01% 3307
2023
Q4
$536K Buy
+127,500
New +$237K ﹤0.01% 3434
2022
Q2
Sell
-86,945
Closed -$733K 3881
2022
Q1
$733K Buy
+86,945
New +$683K ﹤0.01% 3331

Other funds holding ABSI

Ameriprise's ABSI Position: Q2 2026 in Review

Ameriprise increased its Absci (ABSI) stake by 120% in Q2 2026, buying an estimated $21.5M and bringing the position to 6,991,763 shares worth $81M. The position accounts for 0.02% of the portfolio, ranked #701.

Ameriprise first reported a position in ABSI in Q1 2022 and has held it in 12 quarters since. 197 funds tracked by Wall St. Rank hold ABSI as of Q2 2026.

  • Ameriprise held 6,991,763 shares of Absci worth $81M as of Q2 2026.
  • Ameriprise bought 3,811,622 Absci shares in Q2 2026, an estimated $21.5M.
  • Absci made up 0.02% of Ameriprise's portfolio in Q2 2026, its #701 holding.
  • Ameriprise first reported a position in Absci in Q1 2022 and has held it in 12 quarters since.
  • 197 funds tracked by Wall St. Rank held Absci as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.